Zdenkowski N, Kuper-Hommel MJJ, Niman SM, Francis PA, et al. Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial. Lancet Oncol 2025;26:367-377.
PMID: 40049198